Clinical Trials Sponsored by Exactis Innovation

Total 2100 results

French Innovative Leukemia Organisation

Terminated

Treatment With Bendamustine, Ofatumumab and MethylPrednisolone in Relapsed B-CLL (BOMP)

B-cell Chronic Lymphocytic Leukemia (B-CLL)

France
French Innovative Leukemia Organisation

Terminated

Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma

Lymphoma

France
French Innovative Leukemia Organisation

Completed

Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating CLL2007 CLL 2007 FMP

Leukemia

France
Oculus Innovative Sciences, Inc.

Unknown

A Substantial Equivalence Study of RD04723 and Predicate Device

Hypertrophic Scar | Keloid Scar

United States
French Innovative Leukemia Organisation

Completed

Phase III Study Treatment of CLL B and C

Leukemia, Lymphocytic, Chronic
French Innovative Leukemia Organisation

Completed

Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage III

Leukemia, Lymphocytic, Acute

France
French Innovative Leukemia Organisation

Completed

Lomustine and Intermediate Dose Cytarabine in Older Patients With AML

Acute Myeloid Leukemia

France
King's College London
UK Research and Innovation

Not yet recruiting

Structured Tailored Rehabilitation After Hip Fragility Fracture (STRATIFY)

Hip Fractures
Sunnybrook Health Sciences Centre
AFP Innovation Fund

Recruiting

Integrated Patient Avatars for Guiding Systemic Therapy Treatments in Metastatic Breast Cancer Patients

Breast Cancer | Breast Neoplasms | Metastatic Breast Cancer | Cancer, Breast

Canada
Blue Note Therapeutics
Healthcare Innovation Technology Lab

Completed

Blue Note Therapeutics Product BNT 103 Usability and User Engagement

Breast Cancer Female

United States
AO Innovation Translation Center
Berufsgenossenschaftlichen Unfallklinik Tuebingen

Terminated

OpenGo Sensor Insole in Open Wedge HTO (HTO)

Tibia; Angulation

Germany
Indonesia University
PT Paragon Technology and Innovation

Active, not recruiting

Cosmetic Products and Facial Skin Microbiome

Cosmetics Product Effects

Indonesia
University of Calgary
Alberta Innovation and Science

Terminated

Clinical Trial of a Nutritional Supplement in Adults With Bipolar Disorder

Bipolar Disorder

United States, Canada
French Innovative Leukemia Organisation

Recruiting

Prognostic Analyses on a Validation Series of Patients With Waldenström's Disease (SérieProWM)

Waldenstrom's Disease | Prognostic Index

France
QualiMed Innovative Medizinprodukte GmbH

Not yet recruiting

Safety and Efficacy of the QBX Peripheral Balloon Expandable Stent System in Peripheral Artery Disease (PAD) (QBX-RADAR)

Peripheral Arterial Disease

Belgium
Innovative Cellular Therapeutics Inc.

Recruiting

GCC19CART for Patients With Metastatic Colorectal Cancer (CARAPIA-1)

Colorectal Cancer

United States
French Innovative Leukemia Organisation

Recruiting

Venetoclax + Cytarabine Versus Idarubicin + Cytarabine : Efficacity Assessment as Post-remission Therapy to Elderly Patients With Acute Myeloid Leukemia in First Remission (LAMSA2020)

Acute Myeloid Leukemia

France
French Innovative Leukemia Organisation

Recruiting

STop and Restart Acalabrutinib In fRail Patients With Previously Untreated Chronic Lymphocytic Leukemia (STAIR)

Untreated Chronic Lymphocytic Leukemia

France
QualiMed Innovative Medizinprodukte GmbH

Recruiting

UNITY-B A Prospective, Multicentric, Single-arm Study to Evaluate the Safety and Efficacy of the UNITY-B Biodegradable Balloon-Expandable Biliary Stent System in Subjects With Biliary Strictures

Bile Duct Diseases | Biliary Obstruction | Bile Duct Stricture

Hong Kong, India, Malaysia
French Innovative Leukemia Organisation

Recruiting

Preemptive Therapy for High Risk Chronic Lymphoid Leukemia Stage A

Chronic Lymphoid Leukemia

France
French Innovative Leukemia Organisation

Completed

JAK2 Inhibitors RUXOLITINIB in Patients With Myelofibrosis

Myelofibrosis

France
Innovative Med Concepts, LLC

Completed

A Study of IMC-1 In Patients With Fibromyalgia

Chronic Pain | Fibromyalgia | Myofascial Pain

United States
QualiMed Innovative Medizinprodukte GmbH

Unknown

Prospective, Post Market Surveillance Q3-registry (POLARIS) (Q3-Registry)

Peripheral Artery Disease

Germany
Innovative Trauma Care Inc.

Withdrawn

Prospective Evaluation of the iTClamp50 to Provide Temporary Wound Closure

Hemorrhage | Bleeding | Wound Closure

Canada
French Innovative Leukemia Organisation

Completed

Efficacy , Safety of Treatment R NIMP for Relapsed Aggressive Lymphomas

Diffuse Large B-Cell Lymphoma

France
Oculus Innovative Sciences, Inc.

Completed

Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults

Pruritus | Atopic Dermatitis

United States
French Innovative Leukemia Organisation

Completed

High-Dose Therapy Treatment in Patients With Follicular Lymphoma

Follicular Lymphoma

France
French Innovative Leukemia Organisation

Completed

Liposomal Anthracyclin in the Treatment of Elderly ALL

Acute Lymphoblastic Leukemia

France
French Innovative Leukemia Organisation

Completed

Treatment of Disseminated High Grade Lymphoma

Lymphoma

France
French Innovative Leukemia Organisation

Completed

Treatment of Localized Low Grade Lymphomas

Lymphoma, Low-Grade

France
Rostrum Medical Innovations Inc.
Medical Initiatives

Not yet recruiting

Evaluation of VQm PHM on Pulmonary Health Parameters for ICU

Stroke | Pneumonia | COPD | Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS) | Ventilators, Mechanical

France, United States, Austria, Czechia
SCRI Development Innovations, LLC
Seagen Inc.

Recruiting

Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

Breast Cancer

United States
A.M.I. Agency for Medical Innovations GmbH

Recruiting

Safety and Performance of a Silicone Implant for Fecal Incontinence Treatment (SimplyFI)

Fecal Incontinence

Spain, Austria, Germany
Darwin Ang

Recruiting

Rib Fixation for Clinically Severe Rib Fractures From Trauma (SOFRIB)

Flail Chest | Rib Fracture

United States
SCRI Development Innovations, LLC
Incyte Corporation

Terminated

A Study of Itacitinib for the Treatment of Chronic Graft Versus Host Disease (cGVHD)

Chronic Graft-versus-host-disease

United States
SCRI Development Innovations, LLC
Novartis Pharmaceuticals

Completed

A Study of the Hsp90 Inhibitor AUY922 Plus Capecitabine for the Treatment of Patients With Advanced Solid Tumors

Metastatic or Unresectable Solid Tumor Malignancy

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Terminated

Preoperative Chemotherapy and Bevacizumab in Patients With Stage IB (>4 cm), II, or Select Stage III NSCLC

Non-Small Cell Lung Cancer

United States
SCRI Development Innovations, LLC
Celgene Corporation

Completed

Nanoparticle Albumin-Bound (Nab) Paclitaxel/Cyclophosphamide in Early-Stage Breast Cancer

Breast Cancer

United States
Vascular Innovations Co. Ltd.
MedPass International

Completed

Omega™ Left Atrial Appendage (LAA) Occluder in Patients With Non-Valvular Atrial Fibrillation

Atrial Fibrillation

Denmark, Thailand
Boston University
Innovations for Poverty Action

Completed

Evaluation of Novartis Access; a Non-communicable Disease (NCD) Access Initiative

Cardiovascular Disease | Breast Cancer | Asthma | Diabetes Type II
SCRI Development Innovations, LLC
Eisai Inc.

Completed

Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy

Metastatic Breast Cancer

United States
Baxter Healthcare Corporation
Synovis Surgical Innovations

Completed

Reinforcement of Surgical Staple Lines Using Peri-Strips Dry (PSD) With Veritas Collagen Matrix (RESULTS)

Obesity

United States
Baxter Healthcare Corporation
Synovis Surgical Innovations

Withdrawn

Rotator Cuff Repair (RCR) With and Without OrthoADAPT Augmentation

Rotator Cuff Tear

United States
Baxter Healthcare Corporation
Synovis Surgical Innovations

Withdrawn

Acute Achilles Repair With or Without OrthADAPT Augmentation

Achilles Tendon Tear

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

Non Small Cell Lung Cancer Patients Treated With Erlotinib Six Months or Longer

Non Small Cell Lung Cancer

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

Trial of Poor Performance Status Patients (ToPPS) (ToPPS)

Non Small Cell Lung Cancer

United States
SCRI Development Innovations, LLC
Celgene Corporation

Completed

Lenalidomide With Gemcitabine in Treatment of Untreated Advanced Carcinoma of the Pancreas

Metastatic Pancreatic Cancer

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

Treatment of Head & Neck Cancer With Chemotherapy and Radiation

Head and Neck Cancer

United States
Baxter Healthcare Corporation
Baxter Innovations GmbH

Completed

Oxidized Cellulose hEmostAsis evaluatioN (OCEAN)

Intra-operative Bleeding

Czech Republic, Germany, Hungary, Poland
SCRI Development Innovations, LLC
Celgene Corporation

Completed

Community Oncology Setting Cost Analysis and Disease Outcomes of Taxane Use in Metastatic Breast Cancer

Metastatic Breast Cancer

United States

Clinical Trials Sponsored by Exactis Innovation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cyprus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations